HK1048629B - 新化合物 - Google Patents

新化合物

Info

Publication number: HK1048629B
Authority: HK; Hong Kong
Prior art keywords: compounds; iodo; bromo; fluoro; chloro
Prior art date: 1999-12-20

Application number

HK03100303.9A

Other languages

English (en)

Other versions

HK1048629A1 (en

Inventor

Brown William

Walpole Christopher

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-20

Filing date

2003-01-13

Publication date

2004-12-03

2003-01-13 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-04-11 Publication of HK1048629A1 publication Critical patent/HK1048629A1/xx

2004-12-03 Publication of HK1048629B publication Critical patent/HK1048629B/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HK03100303.9A 1999-12-20 2003-01-13 新化合物 HK1048629B (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9904675A SE9904675D0 (sv)	1999-12-20	1999-12-20	Novel compounds
PCT/SE2000/002560 WO2001046263A1 (en)	1999-12-20	2000-12-15	Novel compounds

Publications (2)

Publication Number	Publication Date
HK1048629A1 HK1048629A1 (en)	2003-04-11
HK1048629B true HK1048629B (zh)	2004-12-03

Family

ID=20418211

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK03100303.9A HK1048629B (zh)	1999-12-20	2003-01-13	新化合物

Country Status (32)

Country	Link
US (1)	US6875777B2 (zh)
EP (1)	EP1242406B1 (zh)
JP (1)	JP2003518136A (zh)
KR (1)	KR20020062351A (zh)
CN (1)	CN1185227C (zh)
AT (1)	ATE261957T1 (zh)
AU (1)	AU775648B2 (zh)
BG (1)	BG106807A (zh)
BR (1)	BR0016594A (zh)
CA (1)	CA2394864A1 (zh)
CO (1)	CO5271645A1 (zh)
CZ (1)	CZ20022123A3 (zh)
DE (1)	DE60009148T2 (zh)
DK (1)	DK1242406T3 (zh)
EE (1)	EE200200338A (zh)
ES (1)	ES2215786T3 (zh)
HK (1)	HK1048629B (zh)
HU (1)	HUP0300295A3 (zh)
IL (1)	IL150210A0 (zh)
IS (1)	IS6419A (zh)
MX (1)	MXPA02006064A (zh)
NO (1)	NO20022919L (zh)
NZ (1)	NZ519987A (zh)
PL (1)	PL355843A1 (zh)
PT (1)	PT1242406E (zh)
RU (1)	RU2002114346A (zh)
SE (1)	SE9904675D0 (zh)
SK (1)	SK8842002A3 (zh)
TR (1)	TR200401433T4 (zh)
UA (1)	UA72287C2 (zh)
WO (1)	WO2001046263A1 (zh)
ZA (1)	ZA200204257B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0101770D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101771D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SK287555B6 (sk)	2001-05-18	2011-01-04	Astrazeneca Ab	4-(Fenylpiperazinylmetyl)benzamidové deriváty a ich použitie na liečbu bolesti, anxiety alebo gastrointestinálnych porúch
SE0101773D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101769D0 (sv) *	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
WO2003037342A1 (en) *	2001-10-29	2003-05-08	Ardent Pharmaceuticals, Inc.	Method of treating depression with delta receptor agonist compounds
WO2003057223A1 (en)	2002-01-02	2003-07-17	Ardent Pharmaceuticals, Inc.	Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
US8476280B2 (en) *	2002-05-09	2013-07-02	Versi Group, Llc	Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
KR101234421B1 (ko)	2004-08-02	2013-02-18	아스트라제네카 아베	디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
CN101128447A (zh) *	2005-02-28	2008-02-20	阿斯利康(瑞典)有限公司	二芳基甲基哌嗪衍生物，其制备及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4091096A (en)	1976-03-19	1978-05-23	Eli Lilly And Company	Dinitroanilines for the control of phytopathogens
EG12406A (en)	1976-08-12	1979-03-31	Janssen Pharmaceutica Nv	Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
SE441448B (sv)	1977-05-23	1985-10-07	Pfizer	Sett att framstella hexahydro-gamma-karbolinforeningar
DE3200304A1 (de)	1981-01-16	1982-08-26	Sandoz-Patent-GmbH, 7850 Lörrach	3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3563964D1 (en)	1984-10-16	1988-09-01	Synthelabo	Piperidine derivatives, their preparation and their therapeutical application
YU150489A (sh)	1989-08-10	1992-12-21	W.L. Gore & Co. Gmbh.	Uređaj za ispitivanje odevnih predmeta na nepromočivost
KR940003491B1 (ko)	1989-08-10	1994-04-23	리히터 게데온 베기에스제티 기아르 알.티	4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
US5854245A (en)	1996-06-28	1998-12-29	Merck & Co., Inc.	Fibrinogen receptor antagonists
SE9604786D0 (sv)	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
ZA9811842B (en)	1997-12-24	2000-06-23	Ortho Mcneil Pharm Inc	4-[aryl(piperidin-4-yl)]aminobenzamides.
JP4498602B2 (ja)	1998-03-10	2010-07-07	リサーチ・トライアングル・インスティチュート	新規なオピエート化合物、その調製法及び使用法
US6436959B1 (en) *	1998-12-23	2002-08-20	Ortho-Mcneil Pharmaceutical, Inc.	4-[aryl(piperidin-4-yl)]aminobenzamides

1999
- 1999-12-20 SE SE9904675A patent/SE9904675D0/xx unknown
2000
- 2000-12-15 HU HU0300295A patent/HUP0300295A3/hu unknown
- 2000-12-15 AU AU25644/01A patent/AU775648B2/en not_active Ceased
- 2000-12-15 US US10/149,982 patent/US6875777B2/en not_active Expired - Fee Related
- 2000-12-15 CN CNB00819064XA patent/CN1185227C/zh not_active Expired - Fee Related
- 2000-12-15 CZ CZ20022123A patent/CZ20022123A3/cs unknown
- 2000-12-15 UA UA2002064616A patent/UA72287C2/uk unknown
- 2000-12-15 EP EP00989097A patent/EP1242406B1/en not_active Expired - Lifetime
- 2000-12-15 NZ NZ519987A patent/NZ519987A/en unknown
- 2000-12-15 TR TR2004/01433T patent/TR200401433T4/xx unknown
- 2000-12-15 ES ES00989097T patent/ES2215786T3/es not_active Expired - Lifetime
- 2000-12-15 PL PL00355843A patent/PL355843A1/xx not_active Application Discontinuation
- 2000-12-15 DE DE60009148T patent/DE60009148T2/de not_active Expired - Fee Related
- 2000-12-15 EE EEP200200338A patent/EE200200338A/xx unknown
- 2000-12-15 KR KR1020027007837A patent/KR20020062351A/ko not_active Application Discontinuation
- 2000-12-15 JP JP2001547172A patent/JP2003518136A/ja not_active Abandoned
- 2000-12-15 MX MXPA02006064A patent/MXPA02006064A/es active IP Right Grant
- 2000-12-15 CA CA002394864A patent/CA2394864A1/en not_active Abandoned
- 2000-12-15 SK SK884-2002A patent/SK8842002A3/sk unknown
- 2000-12-15 RU RU2002114346/04A patent/RU2002114346A/ru not_active Application Discontinuation
- 2000-12-15 PT PT00989097T patent/PT1242406E/pt unknown
- 2000-12-15 IL IL15021000A patent/IL150210A0/xx unknown
- 2000-12-15 BR BR0016594-8A patent/BR0016594A/pt not_active IP Right Cessation
- 2000-12-15 AT AT00989097T patent/ATE261957T1/de not_active IP Right Cessation
- 2000-12-15 WO PCT/SE2000/002560 patent/WO2001046263A1/en active IP Right Grant
- 2000-12-15 DK DK00989097T patent/DK1242406T3/da active
- 2000-12-19 CO CO00096315A patent/CO5271645A1/es not_active Application Discontinuation
2002
- 2002-05-28 ZA ZA200204257A patent/ZA200204257B/en unknown
- 2002-06-10 BG BG106807A patent/BG106807A/xx unknown
- 2002-06-12 IS IS6419A patent/IS6419A/is unknown
- 2002-06-18 NO NO20022919A patent/NO20022919L/no not_active Application Discontinuation
2003
- 2003-01-13 HK HK03100303.9A patent/HK1048629B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ519987A (en)	2004-04-30
US20030036552A1 (en)	2003-02-20
AU775648B2 (en)	2004-08-12
BR0016594A (pt)	2002-09-10
AU2564401A (en)	2001-07-03
HUP0300295A2 (hu)	2003-06-28
UA72287C2 (uk)	2005-02-15
IL150210A0 (en)	2002-12-01
WO2001046263A1 (en)	2001-06-28
PT1242406E (pt)	2004-07-30
RU2002114346A (ru)	2004-01-20
NO20022919L (no)	2002-08-02
JP2003518136A (ja)	2003-06-03
SK8842002A3 (en)	2003-05-02
CO5271645A1 (es)	2003-04-30
EE200200338A (et)	2003-10-15
BG106807A (en)	2003-03-31
DK1242406T3 (da)	2004-06-28
SE9904675D0 (sv)	1999-12-20
KR20020062351A (ko)	2002-07-25
HK1048629A1 (en)	2003-04-11
US6875777B2 (en)	2005-04-05
DE60009148T2 (de)	2005-02-03
ZA200204257B (en)	2003-08-28
PL355843A1 (en)	2004-05-17
EP1242406A1 (en)	2002-09-25
NO20022919D0 (no)	2002-06-18
CN1434818A (zh)	2003-08-06
CA2394864A1 (en)	2001-06-28
EP1242406B1 (en)	2004-03-17
CZ20022123A3 (cs)	2002-11-13
TR200401433T4 (tr)	2004-09-21
MXPA02006064A (es)	2002-12-05
ES2215786T3 (es)	2004-10-16
IS6419A (is)	2002-06-12
CN1185227C (zh)	2005-01-19
DE60009148D1 (de)	2004-04-22
HUP0300295A3 (en)	2006-01-30
ATE261957T1 (de)	2004-04-15

Publication	Publication Date	Title
MXPA03010445A (es)	2004-03-09	Derivados de 4(fenil-piperazinil-metil) benzamida y su uso para tratamiento del dolor, ansiedad o trastornos gastrointestinales.
DE69813896D1 (de)	2003-05-28	Alpha-aminoamidderivate die als analgetische mittel nützlich sind
HK1048629A1 (en)	2003-04-11	Novel compounds.
MXPA04003056A (es)	2004-07-05	Derivados de 4?piperidin-4-iliden-(3-carbamoilfenil)metil? benzamida y su uso para tratamiento de dolor, lesiones espinales o transtornos gastrointestinales.
MXPA03010439A (es)	2004-03-09	Derivados de 4-(fenil-piperidin-a-iliden-metil)-benzamida y su uso para tratar dolor, ansiedad o trastornos gastrointestinales.
HK1048113A1 (en)	2003-03-21	Novel compounds
SE0101766D0 (sv)	2001-05-18	Novel compounds
SE0001209D0 (sv)	2000-04-04	Novel compounds
SE0001208D0 (sv)	2000-04-04	Novel compounds
MXPA03010437A (es)	2004-03-09	Derivados de 4-(fenil-piperidin-4-iliden-metil)-benzamida y su uso para tratar dolor, ansiedad o transtornos gastrointestinales.
DE602004031560D1 (de)	2011-04-07	Diazaspiropiperidinderivate
SE0101771D0 (sv)	2001-05-18	Novel compounds
SE0101769D0 (sv)	2001-05-18	Novel compounds
MXPA03010441A (es)	2004-03-09	Derivados de 4-(fenil-(piperidin-4-il)-amino)-benzamida y sus usos para tratamiento del dolor, ansiedad o desordenes gastrointestinales.
DE60006032D1 (de)	2003-11-27	3-(3-Hydroxyphenyl)-3-amino-propionamidderivate

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2008-07-25	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20071215